Yun Zhong

Stock Analyst at BTIG

(0.70)

# 2,981

Out of 4,433 analysts

17

Total ratings

31.82%

Success rate

-20.21%

Average return

Main Sectors:

Top Industries:

10 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVXL Anavex Life Sciences	Maintains: Buy	$35 → $28	$4.55	+515.38%	2	Feb 9, 2023
	TSHA Taysha Gene Therapies	Downgrades: Neutral	n/a	$3.09	-	2	Feb 2, 2023
	FOLD Amicus Therapeutics	Maintains: Buy	$14 → $16	$9.57	+67.19%	1	Jan 18, 2023
	SRPT Sarepta Therapeutics	Maintains: Buy	$125 → $160	$131.38	+21.78%	4	Dec 22, 2022
	AVRO AVROBIO	Upgrades: Buy	$4	$1.39	+187.77%	3	Dec 8, 2022
	RCKT Rocket Pharmaceuticals	Initiates: Buy	$35	$22.62	+54.73%	1	Nov 1, 2022
	BLUE bluebird bio	Downgrades: Hold	n/a	$1.03	-	1	Jul 1, 2021
	QURE uniQure	Initiates: Buy	n/a	$5.01	-	1	Jun 15, 2021
	PASG Passage Bio	Initiates: Buy	n/a	$1.32	-	1	Jun 15, 2021
	MREO Mereo BioPharma Group	Initiates: Buy	n/a	$3.20	-	1	May 5, 2021

Anavex Life Sciences

Feb 9, 2023

Maintains: Buy

Price Target: $35 → $28

Current: $4.55

Upside: +515.38%

Taysha Gene Therapies

Feb 2, 2023

Downgrades: Neutral

Price Target: n/a

Current: $3.09

Upside: -

Amicus Therapeutics

Jan 18, 2023

Maintains: Buy

Price Target: $14 → $16

Current: $9.57

Upside: +67.19%

Sarepta Therapeutics

Dec 22, 2022

Maintains: Buy

Price Target: $125 → $160

Current: $131.38

Upside: +21.78%

AVROBIO

Dec 8, 2022

Upgrades: Buy

Price Target: $4

Current: $1.39

Upside: +187.77%

Rocket Pharmaceuticals

Nov 1, 2022

Initiates: Buy

Price Target: $35

Current: $22.62

Upside: +54.73%

bluebird bio

Jul 1, 2021

Downgrades: Hold

Price Target: n/a

Current: $1.03

Upside: -

uniQure

Jun 15, 2021

Initiates: Buy

Price Target: n/a

Current: $5.01

Upside: -

Passage Bio

Jun 15, 2021

Initiates: Buy

Price Target: n/a

Current: $1.32

Upside: -

Mereo BioPharma Group

May 5, 2021

Initiates: Buy

Price Target: n/a

Current: $3.20

Upside: -